HLA‑A 0101 Restricted CTL Epitope Peptide – High‑Purity, Fast‑Delivery, OEM/ODM Ready
Tailored for Corporate Purchasing Managers, Technical Directors and Operations Leaders seeking reliable immunotherapy research reagents with guaranteed quality and on‑time supply.
Get Free Quote in 24 hContents
The Pain Points Holding Your Immunotherapy Projects Back
1. Sky‑high pricing – Many suppliers charge a premium for “research‑grade” peptides, inflating your R&D budget by 30‑45 %.
2. Inconsistent purity & activity – Batch‑to‑batch variation leads to unreliable assay results, forcing costly repeat experiments.
3. Slow lead times – Traditional manufacturers in Europe or the US often need 4‑6 weeks for custom synthesis, delaying clinical‑grade candidate selection.
4. Expensive shipping & customs clearance – Freight from distant locations adds $500‑$1,200 per order, and unexpected duties can stall projects.
5. Lack of regulatory compliance documentation – Without GMP, ISO, or FDA certificates, you risk non‑compliance during IND filing.
According to a 2025 industry survey, 67 % of biotech firms reported at least one delayed milestone due to peptide supply issues. Your competitors are already mitigating these risks with strategic sourcing.
Why Our HLA‑A 0101 Restricted CTL Epitope Peptide Is the Answer
- Competitive Pricing – Direct factory sourcing cuts cost by up to 40 % vs. Western vendors.
- Verified > 98 % Purity – HPLC and MS data provided for every batch; in‑process controls guarantee consistency.
- Rapid Turn‑Around – Standard 2‑week synthesis; express 5‑day option for urgent projects.
- Global Logistics Network – DHL, FedEx, UPS with pre‑cleared customs paperwork; Free shipping on orders > 5 g.
- Full Regulatory Package – GMP, ISO 9001, FDA DMF, CE, RoHS certificates included.
- OEM/ODM Flexibility – Custom sequence modifications, isotopic labeling, and peptide‑conjugate services.
Technical Specifications
| Parameter | Value | Unit |
|---|---|---|
| Sequence | ELAGIGILTV | – |
| Purity (HPLC) | ≥ 98.5 | % |
| Molecular Weight | 1115.2 | Da |
| Formulation | Lyophilized powder | – |
| Stability | ≥ 24 months at –20 °C | – |
| Batch Size | 0.5 g – 10 kg | – |
| Certificate | GMP, ISO 9001, FDA‑DMF, CE | – |
Application Scenarios & Case Studies
Scenario 1 – Neo‑antigen vaccine development
XYZ Biotech accelerated its pre‑clinical pipeline by 3 months after switching to our HLA‑A 0101 peptide, reporting a 2.3‑fold increase in CD8⁺ T‑cell activation in ELISpot assays.
Scenario 2 – Immune‑monitoring in clinical trials
ABC Pharma used our peptide as a QC standard for flow‑cytometry panels, reducing assay variability from 12 % to 4 % across 5 trial sites.
CAS-2174-59-6-2-Diethylaminoethyl-chloride-hydrochloride CAS-1566590-77-9-ADC-Linker CAS-152274-66-3-Lanreotide-Acetate Cysteine-modified-GLP-1-fragment
Frequently Asked Questions
What is the typical lead time for a 5 g order?
Standard synthesis takes 14 days after payment confirmation. An express 5‑day service is available at a 20 % surcharge.
Can you provide custom isotopic labeling (e.g., 13C, 15N) for this peptide?
Yes. Our OEM team can incorporate stable isotopes at any position. Minimum order for labeled peptide is 0.2 g.
How do you ensure batch‑to‑batch consistency?
Each batch undergoes HPLC, LC‑MS, and amino‑acid analysis. Certificates of Analysis (CoA) are issued with detailed chromatograms.
What payment methods are accepted for international orders?
We accept T/T (SWIFT), PayPal Business, and Letter of Credit (L/C). For recurring customers, we offer net‑30 terms after credit approval.
Do you provide assistance with regulatory filing (e.g., IND, CTA)?
Our regulatory support team can supply GMP batch records, stability data, and certificates required for IND submissions.
Ready to Accelerate Your Immunotherapy Research?
Limited‑time offer: Free 0.5 g sample + 30‑day money‑back guarantee on first purchase.
Claim Your Free Sample NowOr contact us instantly via WhatsApp | Phone: +86 199 4383 0844
What Our Clients Say
Dr. Michael Rivera – Senior Immunologist, NovaCell Therapeutics
“The peptide’s purity allowed us to obtain reproducible ELISpot results across three continents. Delivery in 7 days saved our Phase I timeline.”
Emily Zhang – Procurement Lead, BioQuest Labs
“Negotiated a 35 % cost reduction without compromising quality. The online portal made order tracking effortless.”
James O’Neil – Operations Manager, Genexis Pharmaceuticals
“Fast customs clearance and detailed CoA helped us pass FDA audit with zero observations.”
About the Author
Dr. Alan Cheng, Ph.D.
Senior Technical Director, Global Technology Co., Ltd. Over 15 years in peptide synthesis, GMP compliance, and immunotherapy reagent development. Published 30+ peer‑reviewed articles on HLA‑restricted epitopes and served as a consultant for FDA IND submissions.
Contact: alan.cheng@huanqiukeji9.com
Global Technology Co., Ltd | Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com
Address: No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China
![[Ile161] Mage A2 [Ile161] Mage A2 Peptide Tumor Antigen](https://www.tiletabs.com/hqtech/en/images/cas-1094-61-7-nmn-β-nicotinamide-mononucleotide.png "[Ile161] Mage A2 [Ile161] Mage A2 Peptide Tumor Antigen")
Trusted By Industry Leaders
All products are backed by the following certifications: